KR100558751B1 - Cosmetic composition for skin moisturizing - Google Patents
Cosmetic composition for skin moisturizing Download PDFInfo
- Publication number
- KR100558751B1 KR100558751B1 KR1020040083125A KR20040083125A KR100558751B1 KR 100558751 B1 KR100558751 B1 KR 100558751B1 KR 1020040083125 A KR1020040083125 A KR 1020040083125A KR 20040083125 A KR20040083125 A KR 20040083125A KR 100558751 B1 KR100558751 B1 KR 100558751B1
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- cosmetic composition
- astragalus
- weight
- hyaluronic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 26
- 239000002537 cosmetic Substances 0.000 title claims abstract description 24
- 230000003020 moisturizing effect Effects 0.000 title claims abstract description 23
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 17
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 17
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 17
- 241001247821 Ziziphus Species 0.000 claims abstract description 15
- 235000006533 astragalus Nutrition 0.000 claims abstract description 13
- 241000045403 Astragalus propinquus Species 0.000 claims abstract description 8
- 108091005804 Peptidases Proteins 0.000 claims abstract description 8
- 239000004365 Protease Substances 0.000 claims abstract description 8
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims abstract description 8
- 108090000787 Subtilisin Proteins 0.000 claims abstract description 7
- 244000126002 Ziziphus vulgaris Species 0.000 claims abstract description 4
- 235000008529 Ziziphus vulgaris Nutrition 0.000 claims abstract description 4
- 235000019206 astragalus extract Nutrition 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 3
- 239000004615 ingredient Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 2
- 238000012258 culturing Methods 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims description 2
- 244000005700 microbiome Species 0.000 claims description 2
- 229920005615 natural polymer Polymers 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- 230000037394 skin elasticity Effects 0.000 claims description 2
- 230000002708 enhancing effect Effects 0.000 claims 1
- 241001061264 Astragalus Species 0.000 abstract description 5
- 210000004233 talus Anatomy 0.000 abstract description 5
- 235000019419 proteases Nutrition 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 48
- 230000000052 comparative effect Effects 0.000 description 18
- 230000000694 effects Effects 0.000 description 13
- 210000000434 stratum corneum Anatomy 0.000 description 11
- 210000002510 keratinocyte Anatomy 0.000 description 9
- 230000004069 differentiation Effects 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 150000002632 lipids Chemical class 0.000 description 7
- 230000008591 skin barrier function Effects 0.000 description 6
- 230000004888 barrier function Effects 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000003158 alcohol group Chemical group 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- OQEBBZSWEGYTPG-UHFFFAOYSA-N 3-aminobutanoic acid Chemical compound CC(N)CC(O)=O OQEBBZSWEGYTPG-UHFFFAOYSA-N 0.000 description 2
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 2
- GQODBWLKUWYOFX-UHFFFAOYSA-N Isorhamnetin Natural products C1=C(O)C(C)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 GQODBWLKUWYOFX-UHFFFAOYSA-N 0.000 description 2
- BJBUTJQYZDYRMJ-UHFFFAOYSA-N Kaempferol 3,7-dimethyl ether Chemical compound C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C=C1 BJBUTJQYZDYRMJ-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 2
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 2
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- ZZAJQOPSWWVMBI-UHFFFAOYSA-N calycosin Chemical compound C1=C(O)C(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZZAJQOPSWWVMBI-UHFFFAOYSA-N 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- HKQYGTCOTHHOMP-UHFFFAOYSA-N formononetin Chemical compound C1=CC(OC)=CC=C1C1=COC2=CC(O)=CC=C2C1=O HKQYGTCOTHHOMP-UHFFFAOYSA-N 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 235000008800 isorhamnetin Nutrition 0.000 description 2
- IZQSVPBOUDKVDZ-UHFFFAOYSA-N isorhamnetin Chemical compound C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 IZQSVPBOUDKVDZ-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000005875 quercetin Nutrition 0.000 description 2
- 229960001285 quercetin Drugs 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- MQSZRBPYXNEFHF-UHFFFAOYSA-N rhamnocitrin Chemical compound C=1C(OC)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C=C1 MQSZRBPYXNEFHF-UHFFFAOYSA-N 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- -1 triterpene glucosides Chemical class 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000004378 air conditioning Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical class O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000003398 denaturant Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- RIKPNWPEMPODJD-UHFFFAOYSA-N formononetin Natural products C1=CC(OC)=CC=C1C1=COC2=CC=CC=C2C1=O RIKPNWPEMPODJD-UHFFFAOYSA-N 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- 238000009849 vacuum degassing Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 피부 보습용 화장료 조성물에 관한 것으로, 보다 상세하게는 서브틸신(subtilsin) 프로테아제, 황기(Astragalus membranaceus, Astragalus mongholicus), 대추(Zizyphus jujuba) 및 히알루론산(hyaluronic acid)을 함유하여 피부의 당김, 거칠음, 탄력 부족 현상을 개선하여 주는 피부 보습용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for moisturizing the skin, and more particularly, contains a subtilsin protease, Astragalus membranaceus, Astragalus mongholicus, Zizyphus jujuba, and hyaluronic acid. It relates to a skin moisturizing cosmetic composition that improves roughness, lack of elasticity.
서브틸신 * 황기 * 대추 * 히알루론산 * 당김 * 거칠음 * 보습Subtilisin * Astragalus * Jujube * Hyaluronic Acid * Pull * Roughness * Moisturizing
Description
본 발명은 피부 보습용 화장료 조성물에 관한 것으로, 보다 상세하게는 서브틸신(subtilsin) 프로테아제, 황기(Astragalus membranaceus, Astragalus mongholicus), 대추(Zizyphus jujuba) 및 히알루론산(hyaluronic acid)을 함유하여 피부의 당김, 거칠음, 탄력 부족 현상을 개선하여 주는 피부 보습용 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition for moisturizing the skin, and more particularly, contains a subtilsin protease, Astragalus membranaceus, Astragalus mongholicus, jujube (Zizyphus jujuba) and hyaluronic acid (hyaluronic acid) It relates to a skin moisturizing cosmetic composition that improves roughness, lack of elasticity.
피부는 외부에서부터 순서대로 표피, 진피, 피하 조직의 3개 층으로 크게 구분되며, 체내의 제 기관을 기온 및 습도 변화, 자외선, 기타 물리적, 화학적인 외부 환경의 자극으로부터 보호해 주는 기능이 있다. 특히, 표피에서는 인체 내부의 수분 증발을 방지하는 중요한 역할을 한다. 표피는 외부로부터 순서대로 각질층, 과립층, 유극층, 기저층으로 구분되며, 각질층의 세포들은 벽돌과 같은 역할을 하고, 각질세포 사이의 세포간 지질들은 모르타르와 같은 역할로 작용하여 피부 장벽을 구성한다(J. Invest. Dermatol. 80(Suppl.), 44-49. 1983). 또한, 건강한 사람의 각질세포에는 고농도의 자연보습인자(Natural Moisturing Factor, NMF)가 존재 하여 피부의 수분 보유를 돕는데, 예를 들면 아미노산과 같은 물질은 수용성이기 때문에 효과적으로 수분과 결합하여 피부에서 수분이 건조되는 것을 억제한다(J. Invest. Dermatol. 54, 24-31, 1970).The skin is divided into three layers of epidermis, dermis and subcutaneous tissue in order from the outside, and it protects the organs of the body from temperature and humidity changes, ultraviolet rays and other physical and chemical external stimuli. In particular, the epidermis plays an important role in preventing evaporation of moisture inside the human body. The epidermis is divided into the stratum corneum, granule layer, pore layer, and basal layer in order from the outside, and the cells of the stratum corneum act as bricks, and the intercellular lipids between the stratum corneum act as the mortar to form the skin barrier ( J. Invest.Drmatol. 80 (Suppl.), 44-49. 1983. In addition, the keratinocytes of healthy people have high concentrations of Natural Moisturing Factor (NMF) to help the skin retain moisture. For example, because amino acids such as amino acids are water-soluble, they can effectively combine with moisture Inhibit drying (J. Invest. Dermatol. 54, 24-31, 1970).
그러나, 요즘과 같이 환경의 변화나 생활 패턴의 변화에 따른 냉/난방의 인위적인 온도 조절, 사회 생활에서 발생되는 각종 스트레스와 환경 오염으로 인한 피부 스트레스, 화장 습관에 따른 잦은 세안 및 연령 증가에 따른 자연적인 피부 노화 등의 여러 가지 원인으로 인하여 각질층의 수분이 감소하여 피부가 건조해지고 표면이 거칠게 되며 피부가 푸석거리고 윤기를 잃어 칙칙하게 보이는 등의 현상이 발생하기 때문에 피부 보습제의 필요가 증가하고 있다. However, these days, the artificial temperature control of air conditioning and heating according to the change of environment and life patterns, the skin stress caused by various stresses and environmental pollution that occur in social life, the frequent face wash due to makeup habits and the increase of age Due to various causes such as aging of the skin, the moisture of the stratum corneum decreases, the skin becomes dry, the surface becomes rough, and the skin becomes crumbly and loses luster, and the appearance of dullness occurs.
종래에는 이를 위해 보습제로서 수분을 흡수하는 성질이 있는 휴멕턴트(humectant)나 수분 증발을 방지하는 폐쇄 보습제(Occlusive Moisturizer)를 사용하여 결국 각질층에서의 수분 보유를 증가시키는 하는 방식이 행하여져 왔다. 상기의 휴멕턴트로는 글리세린, 프로필렌글리콜, 1,3-부틸렌글리콜, 폴리에틸렌글리콜, 솔비톨, 2-피롤리돈-5-카르본산나트륨 등의 물질이 있으나, 피부에 도포 시 끈적임이 심하거나 눅진한 느낌이 드는 단점이 있다. 또한, 폐쇄 보습제로는 세라마이드 등의 지질 성분이나 필수지방산 및 지질 복합체 등이 사용되었으나(J. Invest. Dermatol. (5), 731-740, 1994) 유화 제형의 안정도를 유지하는데 난점이 있으며 투명한 젤상의 제품을 제조하는 데에는 부적합한 단점이 있다. Conventionally, a method of increasing moisture retention in the stratum corneum by using a humectant having a property of absorbing moisture or an occlusive moisturizer that prevents evaporation of moisture as a moisturizing agent is used. Examples of the humectants include glycerin, propylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, and 2-pyrrolidone-5-sodium carbonate. There is a drawback to feeling. In addition, as a closed moisturizer, lipid components such as ceramide, essential fatty acids and lipid complexes were used (J. Invest. Dermatol. (5), 731-740, 1994). There are disadvantages inadequate for the manufacture of the tops.
그러나, 최근에는 각질층의 분화가 피부수분의 건조를 막는데 중요하다는 주장이 제기되면서, 기저층의 각질형성세포에서 최외곽 각질층의 각질세포로 발달되 는 분화과정이 정상적으로 행해져야 피부 수분보유장벽으로서의 역할을 할 수 있다는 사실이 밝혀졌다. 즉, 각화의 과정 중 세포는 자연보습인자와 세포간 지질을 생성하게 되고, 그 결과 각질층은 견고하고 유연하게 되어 방어벽으로서의 기능을 할 수 있게 된다는 것이다. 사람의 연령이 증가되면서 피부가 건조해지는 경향을 생리적으로 보면, 각질층의 탈락 시간이 길어지거나 표피세포의 지질 합성능력이 저하되고, 피부 각질층의 보습인자와 지질의 양이 감소되는 것으로 해석할 수 있다. 그러므로, 각질형성세포의 분화를 촉진시킴으로써 피부 장벽의 강화를 유도하여 피부 수분 유지 기능과 외부 환경으로부터의 보호기능을 증진시킬 수 있는 새로운 접근 방법이 가능해졌다.However, in recent years, the claim that differentiation of the stratum corneum is important to prevent drying of the skin moisture, the differentiation process that develops from the basal keratinocytes to the outermost stratum corneum cells should be performed normally as a role as a skin moisture retention barrier It turns out that you can. That is, during the process of keratinization, the cells produce natural moisturizing factors and intercellular lipids, and as a result, the stratum corneum becomes firm and flexible, thus functioning as a barrier. Physiologically, the tendency of the skin to dry with age increases, which can be interpreted as increasing the dropout time of the stratum corneum, decreasing the lipid synthesis ability of epidermal cells, and decreasing the amount of moisturizing factors and lipids in the stratum corneum. . Thus, by accelerating the differentiation of keratinocytes, a new approach has been made that can induce a strengthening of the skin barrier and enhance skin moisture retention and protection from the external environment.
이에, 본 발명자들은 피부의 당김, 거칠음, 윤기 부족 현상 등을 개선하기 위하여 피부 보습 효과가 우수하면서도 피부에 도포시 끈적이거나 눅진하지 않고, 제형 안정도가 우수한 화장료 조성물을 연구한 결과, 서브틸신 프로테아제, 황기, 대추, 및 히알루론산을 함유하는 화장료를 제조하여, 사람의 피부에 도포시 실제로 피부 보습 효과가 뛰어남을 확인하였으며, 이러한 보습 효과가 각질형성세포의 분화를 촉진시킴으로써 피부 장벽의 강화를 유도하여 피부 수분 유지 기능을 향상시킴으로써 이루어졌다는 것을 밝혀내고, 본 발명을 완성하였다. Accordingly, the present inventors studied a cosmetic composition having excellent skin moisturizing effect and no stickiness or slack when applied to the skin to improve skin pulling, roughness, lack of glossiness, etc. The cosmetics containing Astragalus, Jujube, and Hyaluronic Acid were prepared, and when applied to human skin, it was confirmed that the skin moisturizing effect was actually excellent. This moisturizing effect promotes the differentiation of keratinocytes and induces the strengthening of the skin barrier. It was found that this was achieved by improving skin moisture retention function, and completed the present invention.
따라서, 본 발명의 목적은 피부에 대한 보습 효과가 우수하여 피부의 당김, 거칠음, 탄력 부족 현상을 개선하는 피부보습용 화장료 조성물을 제공하는 것이다.
Accordingly, it is an object of the present invention to provide a cosmetic composition for moisturizing the skin which is excellent in moisturizing effect on the skin to improve skin pulling, roughness and lack of elasticity.
상기한 목적을 달성하기 위하여, 본 발명에 따른 피부 보습용 화장료 조성물은 서브틸신 프로테아제, 황기, 대추, 및 히알루론산을 함유하는 것을 특징으로 한다. 보다 바람직하게는, 본 발명에 따른 피부 보습용 화장료 조성물은 조성물 총 중량에 대하여 서브틸신 프로테아제 0.001~10중량%, 황기 추출물 0.001~20중량%, 대추 추출물 0.001~20중량%, 및 히알루론산 0.000001~10중량%를 함유하는 것을 특징으로 한다. In order to achieve the above object, the skin moisturizing cosmetic composition according to the present invention is characterized in that it contains a subtilisin protease, Astragalus, jujube, and hyaluronic acid. More preferably, the cosmetic composition for moisturizing the skin according to the present invention is 0.001 to 10% by weight of the subtilisin protease, 0.001 to 20% by weight of Astragalus extract, 0.001 to 20% by weight of jujube extract, and 0.000001 to hyaluronic acid. It is characterized by containing 10% by weight.
이하, 본 발명을 보다 상세히 설명한다. Hereinafter, the present invention will be described in more detail.
본 발명에 사용된 서브틸신(subtilsin) 프로테아제는 바실러스 균주(Bacillus licheniformis)에서 나오는 알칼리성 단백질 분해효소로써, 피부의 각질을 제거하는 효과가 있다. 상기 서브틸신 프로테아제의 시판제품인 exfocellia은 효소(protease) 안정화 원료로 다양한 제형에서 안정적으로 각질 분해 효능이 있다고 알려져 있다. Subtilsin protease used in the present invention is an alkaline protease from Bacillus licheniformis, and has an effect of removing dead skin cells. Exfocellia, a commercial product of the subtilisin protease, is known to have a keratinizing effect stably in various formulations as a protease stabilizing material.
본 발명에서는 서브틸신 프로테아제로 상기 exfocellia를 사용하며, 본 발명에서 사용되는 exfocellia는 조성물 총 중량에 대하여 0.001~10중량%의 함량으로 사용한다. 0.001중량% 미만에서는 피부에 대한 효과가 미약하며, 10중량%을 초과하는 경우에는 피부에서 끈적임이 심하여 화장료로 적합하지 않다. In the present invention, the above-mentioned exfocellia is used as a subtylsin protease, and the exfocellia used in the present invention is used in an amount of 0.001 to 10% by weight based on the total weight of the composition. If it is less than 0.001% by weight, the effect on the skin is weak, and if it exceeds 10% by weight, the skin is very sticky and not suitable as a cosmetic.
본 발명에 사용된 황기 추출물은 아스트라갈로사이드류(astragalosides)의 사포닌과 아스트라갈란(astragalan) 계통의 다당류, 캠페롤(kaempferol), 퀘르세틴 (quercetin), 이소람네틴(isorhamnetin), 칼리코신(calycosin), 포르모노네틴(formononetin), 람노시트린(rhamnocitrin), 쿠마타케닌(kumatakenin) 등의 플라보노이드류, 아스파라긴, 글루탐산, 프롤린, β-아미노뷰티르산, 아르기닌, 알라닌 등의 아미노산류를 함유하고 있으며, 피부 조직의 재생을 촉진하고, 면역 기능을 보강하여 외부 자극에 대한 방어력을 높여주며, 혈액 순환을 촉진하여 피부에의 영양 공급을 원활하게 하여 주는 효과가 있다. Astragalus extract used in the present invention is saponin of the astragalalosides (astragalosides) and polysaccharides of the astragalalan (astragalan), kaempferol, quercetin (quercetin), isorhamnetin (isorhamnetin), calicosin (calycosin) ), Flavonoids such as formononetin, rhamnocitrin, kumatakenin, amino acids such as asparagine, glutamic acid, proline, β-aminobutyric acid, arginine, alanine, etc. It promotes the regeneration of skin tissues, enhances immune function, enhances defense against external stimuli, and promotes blood circulation to smooth the nutrition supply to the skin.
본 발명에서 사용한 황기 추출물은 Astragalus membranaceus 또는 Astragalus mongholicus의 뿌리를 친수성 용매인 1,3-부틸렌글리콜과 물을 사용하여 추출한 성분을 사용하였으며, 조성물 총 중량에 대하여 0.001~20중량%의 양으로 사용한다. 이는 0.001중량% 미만에서는 피부에 대한 효과가 미약하고 20중량% 초과시에서는 제형 내에 침전이 생길 우려가 있어 화장료로 적합하지 않기 때문이다.Astragalus extract used in the present invention was used to extract the root of Astragalus membranaceus or Astragalus mongholicus using a hydrophilic solvent 1,3-butylene glycol and water, the amount of 0.001 ~ 20% by weight based on the total weight of the composition do. This is because the effect on the skin is less than 0.001% by weight, and if it is more than 20% by weight, there is a possibility of precipitation in the formulation, which is not suitable as a cosmetic.
본 발명에 사용된 대추 추출물은 비타민 A, B2, C, 아미노산, 당류, 단백질, β-카로틴 등이 풍부하며, 스테롤류, 쿠마린류, 플라보노이드류와 올레아놀릭산, 우르솔릭산 등의 트리테르펜 글루코시드류의 화합물을 함유하고 있으며, 피부에서 항염증, 보습, 진정, 주름 완화 등의 효과가 있다. Jujube extract used in the present invention is rich in vitamins A, B2, C, amino acids, sugars, proteins, β-carotene and the like, and triterpene glucosides such as sterols, coumarins, flavonoids and oleanolic acid and ursolic acid. It contains a compound of anti-inflammatory, moisturizing, soothing, wrinkle relief in the skin.
본 발명에서 사용되는 대추 추출물은 Zizyphus jujuba의 열매를 친수성 용매인 1.3-부틸렌글리콜과 물을 사용하여 추출한 성분을 사용하며, 이의 바람직한 함량은 0.001~20중량%이다. 이는 0.001중량% 미만에서는 피부에 대한 효과가 미약하고, 20중량% 초과시에서는 피부안전성에 문제가 발생할 수 있기 때문에 화장료로 적합하지 않기 때문이다. Jujube extract used in the present invention uses a component extracted from the fruit of Zizyphus jujuba using a hydrophilic solvent 1.3-butylene glycol and water, the preferred content thereof is 0.001 ~ 20% by weight. This is because the effect on the skin is less than 0.001% by weight, and the skin safety problem may occur above 20% by weight, so it is not suitable as a cosmetic.
본 발명에 사용된 히알루론산은 미생물을 배양하여 얻어진 천연 고분자 물질로 유리산(free acid) 또는 염(salt)의 형태인 것으로써, 뮤코다당류의 일종으로 인체의 진피층의 결합조직에 존재하여 수분 유지에 중요한 역할을 하는 성분이다. 본 발명에서 사용되는 히알루론산의 바람직한 함량은 0.000001~10중량%이다. 0.000001중량% 미만에서는 피부에 대한 효과가 미약하고, 10중량% 초과시에는 물에 완전히 용해되기가 힘들며 끈적이는 사용감이 나타나므로 화장료로 적합하지 않다.Hyaluronic acid used in the present invention is a natural polymer obtained by culturing microorganisms, which is in the form of free acid or salt, is a kind of mucopolysaccharide, which is present in the connective tissue of the human dermal layer to maintain moisture. It is an ingredient that plays an important role in. The preferred content of hyaluronic acid used in the present invention is 0.000001 to 10% by weight. If it is less than 0.000001% by weight, the effect on the skin is weak, and when it exceeds 10% by weight, it is difficult to dissolve completely in water and it is not suitable as a cosmetic since it has a sticky feeling.
이하, 실시예 및 시험예를 들어 본 발명을 보다 구체적으로 설명하지만, 본 발명이 이들 예로만 한정되는 것은 아니다. Hereinafter, although an Example and a test example are given and this invention is demonstrated more concretely, this invention is not limited only to these examples.
[시험예 1] 각질형성세포 분화 촉진 효과 [Test Example 1] keratinocyte differentiation promoting effect
사람의 각질형성세포를 배양용 플라스크에 넣고 배양하여 약 80% 정도로 성장시킨 후, 하기 표 1의 시료를 각각 5ppm 농도로 첨가하여 4일간 처리한 다음, 요소(urea)나 SDS(sodium dodecyl sulfate) 같은 변성제 및 β-머캅토에탄올(β-mercaptoethanol) 같은 환원제를 혼합하여 용해되는 단백질을 제거하였다. 그 후, 남은 각질층을 310㎚에서의 흡광도를 측정하여 펩타이드 농도를 분석하였으며, 음성대조군인 증류수를 기준(0%)으로 각 시료에 의한 증가량을 비교하여 그 결과를 표 1에 나타내었다.Human keratinocytes were placed in a culture flask, cultured and grown to about 80%, and the samples of Table 1 were each added at a concentration of 5 ppm and treated for 4 days, followed by urea or sodium dodecyl sulfate (SDS). The denatured protein was removed by mixing the same denaturant and reducing agent such as β-mercaptoethanol. Then, the peptide concentration was analyzed by measuring the absorbance at 310 nm of the remaining stratum corneum, and the results are shown in Table 1 by comparing the increase by each sample based on distilled water as a negative control (0%).
상기 결과에서 보는 바와 같이, 본 발명에 사용된 서브틸신 프로테아제, 황기, 대추, 히알루론산 물질의 각질형성세포 분화 촉진효과가 매우 우수함을 확인할 수 있었다.As can be seen from the above results, it was confirmed that the keratinocyte differentiation promoting effect of the subtilisin protease, Astragalus, jujube, hyaluronic acid material used in the present invention is very excellent.
[실시예 1~3 및 비교예 1~3] 피부 보습용 화장료의 제조[Examples 1-3 and Comparative Examples 1-3] Preparation of Cosmetics for Skin Moisturizing
하기 표 2에 나타낸 함량으로 1~8항까지의 수상 파트와 9~12항까지의 알코올파트를 각각 실온에서 용해한 후, 수상을 교반하면서 알코올 파트를 수상에 서서히 첨가하여 가용화하였다. 다음, 알코올 파트의 첨가가 완료된 후 3~5분 가량 교반을 계속한 후, 진공 탈기하여 실시예 1~3 및 비교예 1~3의 화장료의 제조를 완성하였다.After dissolving the water parts up to 1-8 and the alcohol parts up to 9-12 in each of the contents shown in Table 2 at room temperature, the alcohol parts were gradually added to the aqueous phase while solubilizing with stirring. Next, after the addition of the alcohol part was completed, stirring was continued for about 3 to 5 minutes, followed by vacuum degassing to complete the preparation of the cosmetics of Examples 1 to 3 and Comparative Examples 1 to 3.
[시험예 2] 피부 장벽기능 회복 효과Test Example 2 Skin Barrier Function Restoration Effect
무모생쥐(hairless mouse)의 피부에 아세톤을 반복적으로 도포하여 장벽기능을 손상시킨 후, 표피 수분 손실량(TEWL, transdermal water loss)을 servomed사(스웨덴) evaporimeter EP1으로 측정하여 4.0g/㎡/h에 도달하면, 상기 표 2의 조성물이 함유된 시료 각각을 5㎠ 면적에 도포한 후, 표피 수분 손실량을 1시간, 2시간, 4시간, 8시간 경과 후에 측정하여 감소되는 정도를 평가함으로써 장벽기능이 회복되는 정도를 평가하였다. 이때, 공지의 지질혼합물(ceramide : cholesterol : fatty acid의 2:1:1 혼합물)을 양성 대조군으로 사용하였다. 결과는 초기 손상된 장벽 상태에서의 표피 수분 손실량을 기준(100%)으로 하여 시간에 따른 변화를 비교하여 하기 표 3에 나타내었다.After repeatedly applying acetone to the skin of hairless mice, the barrier function was impaired. The epidermal water loss (TEWL) was measured by servomed evaporimeter EP1 and measured at 4.0 g / ㎡ / h. When reaching, each of the samples containing the composition of Table 2 was applied to an area of 5 cm 2, and the barrier function was evaluated by measuring the amount of epidermal moisture loss after 1 hour, 2 hours, 4 hours, and 8 hours. The extent of recovery was evaluated. At this time, a known lipid mixture (2: 1: 1 mixture of ceramide: cholesterol: fatty acid) was used as a positive control. The results are shown in Table 3 below comparing the changes over time based on the amount of epidermal moisture loss in the initial damaged barrier state (100%).
상기 결과에서 보는 바와 같이, 본 발명에 의한 실시예 1~3의 피부 장벽기능 회복 효과가 비교예 1~3에 비하여 매우 우수함을 확인할 수 있었다.As shown in the above results, it was confirmed that the skin barrier function recovery effect of Examples 1 to 3 according to the present invention is very excellent compared to Comparative Examples 1 to 3.
[시험예 3] 피부 수분 함량 증가 효과 [Test Example 3] skin moisture content increase effect
상기 표 2의 조성으로 제조된 화장료 각각에 대하여 피부 보습력 개선효과를 실험하였다. 피부 질환이 없는 20-30대 140명을 대상으로 1조 당 20명 씩 7개조로 나누어, 각 조에 각각 시험예 2에서와 같이 실시예 1~3 및 비교예 1~3과 양성대조군을 주고, 매일 2회씩 1개월간 얼굴 및 전박부에 도포하게 하였다. 미리 도포 시작 전 항온, 항습 조건(24도, 습도 40%)에서 corneometer(CM820 courage Khazaka electronic GmbH, Germany)를 이용하여 피부 전도도를 측정하여 기본 값을 삼고, 1주, 2주, 4주 경과 후 및 도포 중지 후 2주 경과(6주 경과) 후의 피부 전도도를 측정하여 그 증가율을 평가하였다. 그 결과를 하기 표 4에 나타내었다.For each cosmetic prepared in the composition of Table 2 was tested the effect of improving the skin moisturizing power. For 20 people in their 20s and 30s without skin diseases, 20 people per group were divided into 7 sets, and each group was given the same Examples 1 to 3 and Comparative Examples 1 to 3 and a positive control group as in Test Example 2, Twice daily for 1 month on face and forearm. Before starting the application, measure the conductivity of the skin using a corneometer (CM820 courage Khazaka electronic GmbH, Germany) at constant temperature and humidity conditions (24 degrees, 40% humidity), and after 1 week, 2 weeks and 4 weeks And skin conductivity two weeks after application discontinuation (6 weeks) and the rate of increase was evaluated. The results are shown in Table 4 below.
일반적으로 피부 전도도는 피부 수분량에 비례하므로, 상기 표 4의 결과에서 본 발명에 의한 실시예 1~3의 피부 수분 함량 증가 효과가 매우 우수함을 확인할 수 있었다. 또한, 실시예 2 및 3의 경우 사용 중지 2주 후(총 6주 후)에도 다른 예들에 비하여 수분 함량이 높게 유지되는 것으로 보아 장기적인 보습 효과가 있음을 알 수 있었다. In general, the skin conductivity is proportional to the skin moisture content, it was confirmed that the effect of increasing the skin moisture content of Examples 1 to 3 according to the present invention in the results of Table 4. In addition, in the case of Examples 2 and 3, even after two weeks of discontinuation (after six weeks in total), the moisture content was maintained higher than other examples, and thus it was found to have a long-term moisturizing effect.
또한, 시험대상자에 대하여 실시예 1~3 및 비교예 1~3을 사용하고 난 후의 피부 당김, 거칠음, 탄력 변화에 대한 설문조사를 통하여 주관적인 효능 평가를 시행하였다. 설문조사는 피부 당김, 거칠음, 탄력 변화의 각 항목에 대하여 제품의 효과에 대한 만족도를 1~5점(숫자가 클수록 만족도 높음)으로 구분하여 표시하도록 하였으며, 그 결과를 하기 표 5에 나타내었다. In addition, subjects were subjected to subjective efficacy evaluation through a questionnaire survey on skin pulling, roughness and elasticity after using Examples 1-3 and Comparative Examples 1-3. The questionnaire survey was to express the satisfaction level of the product for each item of skin pull, roughness, elasticity change by 1-5 points (the higher the number, the higher the satisfaction), and the results are shown in Table 5 below.
상기 표 5의 결과로부터, 본 발명의 실시예 1~3의 경우가 비교예 1~3에 비하여 피부의 당김, 거칠음, 윤기를 개선하는 효과가 월등함을 알 수 있었다.From the results of Table 5, it can be seen that in the case of Examples 1 to 3 of the present invention, the effect of improving the skin pulling, roughness and gloss is superior to Comparative Examples 1 to 3.
이상에서 설명한 바와 같이, 본 발명에 의한 화장료 조성물은 유효성분으로 서브틸신 프로테아제, 황기 추출물, 대추 추출물, 및 히알루론산을 함유하여 피부 각질형성세포의 분화를 촉진하고 피부 장벽기능을 회복시키며, 피부의 당김, 거칠음을 해소하고 탄력을 증가시키는 효과가 있어 피부 보습용 화장료로서 유용하게 사용될 수 있다.
As described above, the cosmetic composition according to the present invention contains subtylcin protease, Astragalus extract, jujube extract, and hyaluronic acid as an active ingredient to promote the differentiation of keratinocytes of the skin and restore the skin barrier function, It has an effect of relieving pulling and roughness and increasing elasticity, and thus may be usefully used as a skin moisturizing cosmetic.
Claims (6)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040083125A KR100558751B1 (en) | 2004-10-18 | 2004-10-18 | Cosmetic composition for skin moisturizing |
JP2005300946A JP5016212B2 (en) | 2004-10-18 | 2005-10-14 | Cosmetic composition for moisturizing skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020040083125A KR100558751B1 (en) | 2004-10-18 | 2004-10-18 | Cosmetic composition for skin moisturizing |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100558751B1 true KR100558751B1 (en) | 2006-03-14 |
Family
ID=36380436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020040083125A Expired - Fee Related KR100558751B1 (en) | 2004-10-18 | 2004-10-18 | Cosmetic composition for skin moisturizing |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP5016212B2 (en) |
KR (1) | KR100558751B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100886201B1 (en) | 2006-06-30 | 2009-03-05 | 주식회사 사임당화장품 | Cosmetic composition for skin moisturizing containing Jecheon acid Astragalus extract prepared by ultrasonic extraction |
KR101274606B1 (en) * | 2010-03-15 | 2013-06-13 | 주식회사 코씨드바이오팜 | Cosmetic composition containing the extract of jujube extracted with high pressure |
KR101415993B1 (en) * | 2007-11-30 | 2014-07-16 | (주)아모레퍼시픽 | Composition for skin external application comprising Astragalus Membranaceus extract prepared by using pottery extractor |
KR101456050B1 (en) | 2013-12-02 | 2014-11-04 | 주식회사 엘지생활건강 | Anti-wrinkle cosmetic composition |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101082644B1 (en) * | 2004-04-16 | 2011-11-10 | (주)아모레퍼시픽 | Cosmetic composition for moisturizing |
DE102016111592A1 (en) * | 2016-06-24 | 2017-12-28 | Christian Fach | Glykosaminoglykan contained substance mixture and a process for its preparation and its use |
WO2018208530A1 (en) * | 2017-05-07 | 2018-11-15 | Locus Ip Company, Llc | Cosmetic compositions for skin health and methods of using same |
CN116322612A (en) * | 2021-01-15 | 2023-06-23 | 株式会社Lg生活健康 | Composition for exfoliating or improving skin condition |
KR102825923B1 (en) | 2023-12-07 | 2025-06-27 | 주식회사 제이투케이바이오 | Cosmetic composition for anti-acne containing complex extract of natural product |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63156707A (en) | 1986-12-19 | 1988-06-29 | Yakult Honsha Co Ltd | Cosmetic containing hyaluronic acid |
JPH01117815A (en) * | 1987-10-29 | 1989-05-10 | Pola Chem Ind Inc | External preparation for skin |
KR960022990A (en) * | 1994-12-05 | 1996-07-18 | 성재갑 | Cosmetic soap composition |
KR100229280B1 (en) | 1996-12-26 | 1999-11-01 | 손경식 | Antipruritic moisturizing compositions containing amino acid of soybean waste and inorganic salts |
KR20010075285A (en) * | 1998-09-22 | 2001-08-09 | 데이비드 엠 모이어 | Personal care compositions containing subtilisin enzymes bound to water insoluble substrates |
US6509021B1 (en) | 1995-08-23 | 2003-01-21 | Henkel Kommanditgesellschaft Auf Aktien | Use of mutated subtilisin protease in cosmetic products |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5993011A (en) * | 1982-11-16 | 1984-05-29 | Ichimaru Fuarukosu Kk | Cosmetic containing extract of jujube fruit |
JPH0611686B2 (en) * | 1985-05-17 | 1994-02-16 | ポーラ化成工業株式会社 | Cosmetics |
JPS62257393A (en) * | 1986-05-01 | 1987-11-09 | Yakult Honsha Co Ltd | Production of hyaluronic acid |
JP2000119155A (en) * | 1998-10-14 | 2000-04-25 | Kose Corp | Skin lotion |
JP2002068954A (en) * | 2000-08-25 | 2002-03-08 | Shiseido Co Ltd | Composition for external use for moisture retention |
WO2002022101A1 (en) * | 2000-09-13 | 2002-03-21 | The Procter & Gamble Company | Cosmetic method |
EP1354580A1 (en) * | 2000-12-28 | 2003-10-22 | Shiseido Company Limited | Agents for inhibiting or restoring skin damage caused by drying and method of evaluating the same |
US7223386B2 (en) * | 2002-03-11 | 2007-05-29 | Dow Corning Corporation | Preparations for topical skin use and treatment |
JP2004161658A (en) * | 2002-11-12 | 2004-06-10 | Takekatsu Shibata | Skin care preparation for external use |
KR101082644B1 (en) * | 2004-04-16 | 2011-11-10 | (주)아모레퍼시픽 | Cosmetic composition for moisturizing |
-
2004
- 2004-10-18 KR KR1020040083125A patent/KR100558751B1/en not_active Expired - Fee Related
-
2005
- 2005-10-14 JP JP2005300946A patent/JP5016212B2/en not_active Expired - Fee Related
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63156707A (en) | 1986-12-19 | 1988-06-29 | Yakult Honsha Co Ltd | Cosmetic containing hyaluronic acid |
JPH01117815A (en) * | 1987-10-29 | 1989-05-10 | Pola Chem Ind Inc | External preparation for skin |
KR960022990A (en) * | 1994-12-05 | 1996-07-18 | 성재갑 | Cosmetic soap composition |
US6509021B1 (en) | 1995-08-23 | 2003-01-21 | Henkel Kommanditgesellschaft Auf Aktien | Use of mutated subtilisin protease in cosmetic products |
KR100229280B1 (en) | 1996-12-26 | 1999-11-01 | 손경식 | Antipruritic moisturizing compositions containing amino acid of soybean waste and inorganic salts |
KR20010075285A (en) * | 1998-09-22 | 2001-08-09 | 데이비드 엠 모이어 | Personal care compositions containing subtilisin enzymes bound to water insoluble substrates |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100886201B1 (en) | 2006-06-30 | 2009-03-05 | 주식회사 사임당화장품 | Cosmetic composition for skin moisturizing containing Jecheon acid Astragalus extract prepared by ultrasonic extraction |
KR101415993B1 (en) * | 2007-11-30 | 2014-07-16 | (주)아모레퍼시픽 | Composition for skin external application comprising Astragalus Membranaceus extract prepared by using pottery extractor |
KR101274606B1 (en) * | 2010-03-15 | 2013-06-13 | 주식회사 코씨드바이오팜 | Cosmetic composition containing the extract of jujube extracted with high pressure |
KR101456050B1 (en) | 2013-12-02 | 2014-11-04 | 주식회사 엘지생활건강 | Anti-wrinkle cosmetic composition |
Also Published As
Publication number | Publication date |
---|---|
JP5016212B2 (en) | 2012-09-05 |
JP2006111630A (en) | 2006-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8101214B2 (en) | Composition for skin external application containing complex of herbal extracts | |
US7381436B2 (en) | Cosmetic composition in particular with anti-ageing activity comprising an extract of Aframomum angustifolium or longoza plant | |
KR20100135871A (en) | Active ingredient that stimulates proliferation and / or activity of fibroblasts | |
CN110974758A (en) | Moisture mask and preparation method thereof | |
US6193975B1 (en) | Use of potentilla erecta extract in the cosmetic and pharmaceutical field | |
KR101775074B1 (en) | Composition for permanent wave | |
KR101082644B1 (en) | Cosmetic composition for moisturizing | |
KR20050110720A (en) | Cosmetic composition for moisturizing effect on the skin | |
KR100558751B1 (en) | Cosmetic composition for skin moisturizing | |
KR20050103903A (en) | Topical composition and methods for treatment of aged or environmentally damaged skin | |
CN107951759A (en) | A kind of facial mask liquid and preparation method thereof and facial mask | |
CN110897958A (en) | Anti-aging composition and application thereof | |
KR20150086922A (en) | Composition for relieving skin irritation and moisturizing skin containing natural fermented pine leaf extract | |
JP2001131049A (en) | Skin preparation for external use | |
JP5377815B2 (en) | Cosmetic composition for enhancing skin elasticity | |
CN108836904A (en) | A kind of skin care compositions of wrinkle reduction and the preparation method and application thereof | |
CN113081942A (en) | Multi-dimensional hydration cream containing apple stem cells | |
JP5175744B2 (en) | Cosmetic composition containing Kaimatsuko extract as an active ingredient | |
KR101154772B1 (en) | Cosmetic composition containing the zizyphus jujuba fruit extract and walnut extract for moisturizing effect on the skin | |
CN106176360A (en) | A kind of nectar frost containing oral shui solution extract, Herba Saussureae Involueratae extract and Echinacea Angustifolia extracts and preparation method thereof | |
KR20050110719A (en) | Cosmetic composition for moisturizing effect on the skin | |
JPH11158054A (en) | Skin lotion | |
KR102285828B1 (en) | Cosmetic composition containing skin strengthening composition and method for producing same | |
CN109662938B (en) | Plant polysaccharide moisturizing factor and preparation method and application thereof | |
CN113730289A (en) | Eye and lip care composition with multiple repairing effects and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20041018 |
|
PA0201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20060220 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20060302 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20060303 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20090213 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20100218 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20100218 Start annual number: 5 End annual number: 5 |
|
LAPS | Lapse due to unpaid annual fee | ||
PC1903 | Unpaid annual fee |